BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 24936955)

  • 1. Parity and pancreatic cancer risk: evidence from a meta-analysis of twenty epidemiologic studies.
    Zhu B; Zou L; Han J; Chen W; Shen N; Zhong R; Li J; Chen X; Liu C; Shi Y; Miao X
    Sci Rep; 2014 Jun; 4():5313. PubMed ID: 24936955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parity and pancreatic cancer risk: a dose-response meta-analysis of epidemiologic studies.
    Guan HB; Wu L; Wu QJ; Zhu J; Gong T
    PLoS One; 2014; 9(3):e92738. PubMed ID: 24658609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Older age at first birth is a risk factor for pancreatic cancer: a meta-analysis.
    Luo AJ; Feng RH; Wang XW; Wang FZ
    Hepatobiliary Pancreat Dis Int; 2016 Apr; 15(2):125-30. PubMed ID: 27020627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parity, other reproductive factors, and risk of pancreatic cancer mortality in a large cohort of U.S. women (United States).
    Teras LR; Patel AV; Rodriguez C; Thun MJ; Calle EE
    Cancer Causes Control; 2005 Nov; 16(9):1035-40. PubMed ID: 16184468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parity and endometrial cancer risk: a meta-analysis of epidemiological studies.
    Wu QJ; Li YY; Tu C; Zhu J; Qian KQ; Feng TB; Li C; Wu L; Ma XX
    Sci Rep; 2015 Sep; 5():14243. PubMed ID: 26373341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parity and bladder cancer risk: a dose-response meta-analysis.
    Bai Y; Wang X; Yang Y; Tang Y; Wang J; Han P
    BMC Cancer; 2017 Jan; 17(1):31. PubMed ID: 28061845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parity, reproductive factors, and the risk of pancreatic cancer in women.
    Skinner HG; Michaud DS; Colditz GA; Giovannucci EL; Stampfer MJ; Willett WC; Fuchs CS
    Cancer Epidemiol Biomarkers Prev; 2003 May; 12(5):433-8. PubMed ID: 12750238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproductive factors, menopausal hormone therapies and primary liver cancer risk: a systematic review and dose-response meta-analysis of observational studies.
    Zhong GC; Liu Y; Chen N; Hao FB; Wang K; Cheng JH; Gong JP; Ding X
    Hum Reprod Update; 2016 Dec; 23(1):126-138. PubMed ID: 27655589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Number of parity and the risk of gallbladder cancer: a systematic review and dose-response meta-analysis of observational studies.
    Guo P; Xu C; Zhou Q; Zhou J; Zhao J; Si Z; Shen C; Feng C
    Arch Gynecol Obstet; 2016 May; 293(5):1087-96. PubMed ID: 26408005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parity and kidney cancer risk: evidence from epidemiologic studies.
    Guan HB; Wu QJ; Gong TT
    Cancer Epidemiol Biomarkers Prev; 2013 Dec; 22(12):2345-53. PubMed ID: 24108791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parity, age at first birth, and risk of death from pancreatic cancer: evidence from a cohort in Taiwan.
    Chang CC; Chiu HF; Yang CY
    Pancreas; 2010 Jul; 39(5):567-71. PubMed ID: 20173674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parity and risk of lung cancer in women: systematic review and meta-analysis of epidemiological studies.
    Dahabreh IJ; Trikalinos TA; Paulus JK
    Lung Cancer; 2012 May; 76(2):150-8. PubMed ID: 22169171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between selenium intake and the risk of pancreatic cancer: a meta-analysis of observational studies.
    Wang L; Wang J; Liu X; Liu Q; Zhang G; Liang L
    Biosci Rep; 2016 Oct; 36(5):. PubMed ID: 27623938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproductive factors, exogenous hormone use, and risk of pancreatic cancer in postmenopausal women.
    Kabat GC; Kamensky V; Rohan TE
    Cancer Epidemiol; 2017 Aug; 49():1-7. PubMed ID: 28521283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parity and thyroid cancer risk: a meta-analysis of epidemiological studies.
    Zhu J; Zhu X; Tu C; Li YY; Qian KQ; Jiang C; Feng TB; Li C; Liu GJ; Wu L
    Cancer Med; 2016 Apr; 5(4):739-52. PubMed ID: 26714593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin E intake and pancreatic cancer risk: a meta-analysis of observational studies.
    Peng L; Liu X; Lu Q; Tang T; Yang Z
    Med Sci Monit; 2015 May; 21():1249-55. PubMed ID: 25929754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total fat consumption and pancreatic cancer risk: a meta-analysis of epidemiologic studies.
    Shen QW; Yao QY
    Eur J Cancer Prev; 2015 Jul; 24(4):278-85. PubMed ID: 25089377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal parity and the risk of congenital heart defects in offspring: a dose-response meta-analysis of epidemiological observational studies.
    Feng Y; Yu D; Chen T; Liu J; Tong X; Yang L; Da M; Shen S; Fan C; Wang S; Mo X
    PLoS One; 2014; 9(10):e108944. PubMed ID: 25295723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin and nonsteroidal anti-inflammatory drug use and risk of pancreatic cancer: a meta-analysis.
    Larsson SC; Giovannucci E; Bergkvist L; Wolk A
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2561-4. PubMed ID: 17164387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Association between Leisure Time Physical Activity and Pancreatic Cancer Risk in Adults: A Systematic Review and Meta-analysis.
    Farris MS; Mosli MH; McFadden AA; Friedenreich CM; Brenner DR
    Cancer Epidemiol Biomarkers Prev; 2015 Oct; 24(10):1462-73. PubMed ID: 26174790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.